Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users - Hallo friendsTHE LEK NEWS, In the article you read this time with the title Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users
link : Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users

Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users

Study Backs Hepatitis C Treatment in Injection Drug Users
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Use of sofosbuvir-velpatasvir to treat hepatitis C virus (HCV) infection in injection drug users usually leads to a sustained virologic response at 12 weeks, according to an industry-supported study in the Lancet Gastroenterology & Hepatology.

Read more: http://ift.tt/2FgB8xF

Thus Article Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users

That's an article Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Epclusa - Study Backs Hepatitis C Treatment in Injection Drug Users with the link address https://theleknews.blogspot.com/2018/01/epclusa-study-backs-hepatitis-c.html

Tweet

Subscribe to receive free email updates: